Osilodrostat is a potent cortisol synthesis inhibitor indicated for the treatment of adult patients with Cushing’s disease. As an 11β-hydroxylase inhibitor, this pharmaceutical agent works by suppressing… Read more
Osilodrostat is a potent cortisol synthesis inhibitor indicated for the treatment of adult patients with Cushing’s disease. As an 11β-hydroxylase inhibitor, this pharmaceutical agent works by suppressing the excessive production of cortisol, helping to manage the underlying cause of the condition. To support rigorous quality control and regulatory compliance, pharmaceutical laboratories utilize high-quality reference standards of the active pharmaceutical ingredient, alongside its racemic and enantiomeric forms. This category includes essential materials for impurity profiling, such as synthetic process-related impurities and degradation products, which are vital for establishing safety profiles during method validation. Furthermore, the availability of specific metabolites, such as glucuronides and hydroxy derivatives, facilitates accurate metabolic studies. Researchers also rely on stable isotope-labelled compounds, such as deuterated analogs, as internal standards in liquid chromatography-mass spectrometry (LC-MS) assays to ensure precision and accuracy in the quantitative analysis of drug substance and patient samples.